NCT05433402
Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer treatment 1 / 2 withdrawn NCT04907643
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes No drug interventions supportive_care Not Available recruiting NCT06490536
The Sagittarius Trial treatment 3 not_yet_recruiting NCT00309530
Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C treatment 3 completed NCT04342676
Lymph Node Ratio and Kras Mutation in R Colon Cancer basic_science 3 completed NCT05194878
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers No drug interventions treatment 3 recruiting NCT04488159
Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer treatment 3 not_yet_recruiting NCT05310565
The Effects of Chiropractic in Adults With Colon Cancer No drug interventions other Not Available withdrawn NCT05179889
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer treatment 2 / 3 enrolling_by_invitation NCT06108310
ArTificial inTelligence-based RAdiogenomics in Colon Tumors No drug interventions Not Available Not Available recruiting NCT05174169
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease No drug interventions treatment 2 / 3 recruiting NCT00551421
Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer treatment 1 / 2 completed NCT03803553
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer treatment 3 recruiting NCT00138177
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors treatment 1 completed NCT02836977
Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection treatment Not Available unknown_status NCT02280278
Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy No drug interventions treatment 3 unknown_status NCT00025337
Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated treatment 3 completed NCT05870800
Neoadjuvant Chemoimmunotherapy for Resectable Non-Metastatic Proficient Mismatch Repair (PMMR) Colon Cancer treatment 2 not_yet_recruiting NCT00005818
SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer treatment 1 / 2 completed NCT00028496
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer treatment 1 completed NCT03958435
Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery No drug interventions Not Available Not Available unknown_status NCT01158274
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors treatment 1 completed NCT00079274
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer treatment 3 completed NCT00433576
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery treatment 1 completed NCT00089362
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors treatment 1 completed NCT03422601
Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment No drug interventions Not Available Not Available unknown_status NCT00134069
Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer treatment 1 completed NCT06287814
French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC) No drug interventions Not Available Not Available not_yet_recruiting NCT03154190
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer No drug interventions health_services_research Not Available unknown_status NCT04416490
Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer No drug interventions Not Available Not Available active_not_recruiting NCT01191684
Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer treatment 1 completed NCT02250053
Exercise and Colon Cancer No drug interventions treatment Not Available completed NCT00019006
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer No drug interventions treatment 1 completed NCT01890213
Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer No drug interventions treatment 1 completed NCT02129218
Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer No drug interventions supportive_care Not Available completed NCT03255434
LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy treatment 2 active_not_recruiting NCT01606124
Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer treatment 2 terminated NCT00003835
Combination Chemotherapy in Treating Patients With Stage III Colon Cancer treatment 3 completed NCT00070122
Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer treatment 3 terminated NCT04044430
Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer treatment 1 terminated NCT00101348
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu treatment 1 completed NCT00004931
Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer treatment 3 completed NCT00087191
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer diagnostic Not Available terminated NCT05062889
Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients treatment 2 recruiting NCT03827044
Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer treatment 3 terminated NCT04164069
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab prevention 1 active_not_recruiting NCT01126346
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) No drug interventions supportive_care Not Available completed